RxSight Inc.

NASDAQ: RXST · Real-Time Price · USD
8.41
0.19 (2.31%)
At close: Aug 15, 2025, 3:59 PM
8.47
0.71%
After-hours: Aug 15, 2025, 07:51 PM EDT

RxSight Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
33.64M 37.9M 40.21M 45.41M 34.89M 29.51M 28.58M 30.67M 20.81M 17.49M 16.09M 12.62M 11.36M 8.94M 8.43M 5.79M 4.9M 3.48M
Cost of Revenue
8.45M 9.57M 11.43M 20.19M 10.64M 8.83M 10.93M 16.94M 8.79M 7.12M 8.67M 7.26M 6.57M 5.18M 5.56M 4.45M 5.71M 2.37M
Gross Profit
25.19M 28.33M 28.79M 25.22M 24.25M 20.68M 17.65M 13.73M 12.02M 10.37M 7.42M 5.36M 4.79M 3.76M 2.87M 1.34M -812K 1.12M
Operating Income
-14M -10.67M -8.63M -9.23M -8.33M -10.67M -10.85M -12.51M -13.63M -13.1M -14.99M -15.96M -15.79M -16.58M -14.67M -13.11M -13.88M -11.13M
Interest Income
n/a 2.51M 2.71M 2.91M 2.28M 1.58M 1.66M 1.75M 1.78M 1.39M 836K 439K 196K 46K 11K 11K 15K 17K
Pretax Income
-11.75M -8.17M -5.93M -6.33M -6.06M -9.09M -9.2M -12.4M -13.78M -13.21M -15.61M -16.82M -16.73M -17.59M -15.73M -12.68M -13.47M -6.8M
Net Income
-11.79M -8.19M -5.94M -6.34M -6.08M -9.1M -9.18M -12.41M -13.8M -14.83M -15.61M -16.82M -16.73M -17.6M -15.73M -12.67M -13.48M -6.8M
Selling & General & Admin
28.98M 28.64M 28.21M 25.61M 24.29M 23.32M 21.16M 19.14M 18.24M 16.25M 15.73M 14.93M 14.39M 13.62M 11.62M 9.08M 6.5M 5.61M
Research & Development
10.22M 10.37M 9.21M 8.84M 8.29M 8.03M 7.34M 7.1M 7.4M 7.21M 6.68M 6.39M 6.19M 6.72M 5.92M 5.38M 6.56M 6.64M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
39.19M 39M 37.42M 34.45M 32.58M 31.36M 28.51M 26.24M 25.64M 23.46M 22.41M 21.31M 20.58M 20.34M 17.54M 14.45M 13.06M 12.25M
Interest Expense
5K -6K 5K 5K 6K 6K 4K 230K 1.57M 1.51M 1.45M 1.3M 1.14M 1.06M 1.08M 1.08M 826K 698K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
47.64M 48.57M 48.84M 54.63M 43.22M 40.18M 39.43M 43.18M 34.44M 30.59M 31.08M 28.57M 27.15M 25.52M 23.09M 18.9M 18.77M 14.62M
Income Tax Expense
32K 18K 12K 13K 16K 9K -18K 12K 26K 1.62M 5K n/a n/a 4K 2K -4K 3K 7K
Shares Outstanding (Basic)
40.74M 40.51M 40.36M 39.79M 38.46M 36.84M 35.96M 35.66M 34.5M 31.64M 27.99M 27.67M 27.56M 27.43M 27.32M 18.64M 26.29M 19.07M
Shares Outstanding (Diluted)
40.74M 40.51M 40.36M 39.79M 38.46M 36.84M 35.96M 35.66M 34.5M 31.64M 27.99M 27.67M 27.56M 27.43M 27.35M 18.73M 26.29M 19.07M
EPS (Basic)
-0.29 -0.2 -0.15 -0.16 -0.16 -0.25 -0.26 -0.35 -0.4 -0.47 -0.56 -0.61 -0.61 -0.64 -0.58 -0.68 -0.51 -0.36
EPS (Diluted)
-0.29 -0.2 -0.15 -0.16 -0.16 -0.25 -0.26 -0.35 -0.4 -0.47 -0.56 -0.61 -0.61 -0.64 -0.58 -0.68 -0.51 -0.36
EBITDA
-14M -10.67M -5.4M -5.18M -5.24M -7.95M -8.11M -11.04M -11.18M -10.71M -13.19M -14.54M -14.55M -15.5M -13.64M -12.09M -11.65M -5.13M
EBIT
-11.75M -8.17M -5.92M -6.32M -6.06M -9.09M -9.19M -12.17M -12.21M -11.71M -14.15M -15.52M -15.6M -16.53M -14.65M -11.6M -12.65M -6.1M
Depreciation & Amortization
n/a 785K 523K 1.14M 820K 1.14M 1.08M 1.13M 1.03M 1.39M 836K 980K 1.24M 1.08M 1.02M 1.01M 993K 966K